Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD

100.58  +1.04 (+1.04%)

After market: 100.58 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ADUS. ADUS was compared to 102 industry peers in the Health Care Providers & Services industry. ADUS scores excellent on profitability, but there are some minor concerns on its financial health. ADUS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ADUS was profitable.
ADUS had a positive operating cash flow in the past year.
ADUS had positive earnings in each of the past 5 years.
In the past 5 years ADUS always reported a positive cash flow from operatings.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.21%, ADUS is in the better half of the industry, outperforming 79.05% of the companies in the same industry.
ADUS has a better Return On Equity (7.58%) than 67.62% of its industry peers.
ADUS has a better Return On Invested Capital (6.17%) than 62.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is in line with the industry average of 9.13%.
Industry RankSector Rank
ROA 5.21%
ROE 7.58%
ROIC 6.17%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 6.37%, ADUS belongs to the top of the industry, outperforming 81.90% of the companies in the same industry.
In the last couple of years the Profit Margin of ADUS has grown nicely.
ADUS's Operating Margin of 8.89% is fine compared to the rest of the industry. ADUS outperforms 78.10% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
ADUS has a Gross Margin (32.48%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ADUS has grown nicely.
Industry RankSector Rank
OM 8.89%
PM (TTM) 6.37%
GM 32.48%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

ADUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ADUS has more shares outstanding
ADUS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ADUS is higher compared to a year ago.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.00 indicates that ADUS is not in any danger for bankruptcy at the moment.
The Altman-Z score of ADUS (4.00) is better than 77.14% of its industry peers.
ADUS has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.98, ADUS belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that ADUS is not too dependend on debt financing.
The Debt to Equity ratio of ADUS (0.23) is better than 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.98
Altman-Z 4
ROIC/WACC0.73
WACC8.41%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ADUS has a Current Ratio of 1.67. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
ADUS has a Current ratio (1.67) which is comparable to the rest of the industry.
ADUS has a Quick Ratio of 1.67. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ADUS (1.67) is better than 63.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.19% over the past year.
ADUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.61% yearly.
Looking at the last year, ADUS shows a quite strong growth in Revenue. The Revenue has grown by 9.06% in the last year.
The Revenue has been growing by 12.22% on average over the past years. This is quite good.
EPS 1Y (TTM)16.19%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%4.55%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%7.52%

3.2 Future

Based on estimates for the next years, ADUS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.50% on average per year.
ADUS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.53% yearly.
EPS Next Y17.67%
EPS Next 2Y13.8%
EPS Next 3Y12.85%
EPS Next 5Y10.5%
Revenue Next Year22.18%
Revenue Next 2Y13.7%
Revenue Next 3Y11.71%
Revenue Next 5Y8.53%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.19, the valuation of ADUS can be described as rather expensive.
ADUS's Price/Earnings ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 67.62% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.78, ADUS is valued a bit cheaper.
ADUS is valuated correctly with a Price/Forward Earnings ratio of 16.31.
Based on the Price/Forward Earnings ratio, ADUS is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
ADUS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.19
Fwd PE 16.31
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ADUS is valued a bit cheaper than 72.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.56
EV/EBITDA 16.75
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 12.85% in the coming years.
PEG (NY)1.09
PEG (5Y)1.16
EPS Next 2Y13.8%
EPS Next 3Y12.85%

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (4/25/2025, 8:00:00 PM)

After market: 100.58 0 (0%)

100.58

+1.04 (+1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners103.89%
Inst Owner Change-49.54%
Ins Owners1.73%
Ins Owner Change4.47%
Market Cap1.83B
Analysts82.22
Price Target138.41 (37.61%)
Short Float %3.63%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.1%
Min EPS beat(2)-0.68%
Max EPS beat(2)0.48%
EPS beat(4)3
Avg EPS beat(4)4.41%
Min EPS beat(4)-0.68%
Max EPS beat(4)9%
EPS beat(8)7
Avg EPS beat(8)5.58%
EPS beat(12)10
Avg EPS beat(12)4.98%
EPS beat(16)11
Avg EPS beat(16)3.83%
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-1.83%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.07%
Revenue beat(12)0
Avg Revenue beat(12)-1.47%
Revenue beat(16)0
Avg Revenue beat(16)-1.97%
PT rev (1m)-0.42%
PT rev (3m)-2.82%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)-2.59%
EPS NY rev (1m)1.49%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)1.23%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 19.19
Fwd PE 16.31
P/S 1.58
P/FCF 16.56
P/OCF 15.7
P/B 1.88
P/tB N/A
EV/EBITDA 16.75
EPS(TTM)5.24
EY5.21%
EPS(NY)6.17
Fwd EY6.13%
FCF(TTM)6.08
FCFY6.04%
OCF(TTM)6.41
OCFY6.37%
SpS63.54
BVpS53.41
TBVpS-6.04
PEG (NY)1.09
PEG (5Y)1.16
Profitability
Industry RankSector Rank
ROA 5.21%
ROE 7.58%
ROCE 8.17%
ROIC 6.17%
ROICexc 6.69%
ROICexgc 99.81%
OM 8.89%
PM (TTM) 6.37%
GM 32.48%
FCFM 9.56%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.98
Debt/EBITDA 1.88
Cap/Depr 44.72%
Cap/Sales 0.52%
Interest Coverage 15.75
Cash Conversion 100.18%
Profit Quality 149.98%
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 4
F-Score5
WACC8.41%
ROIC/WACC0.73
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)16.19%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%4.55%
EPS Next Y17.67%
EPS Next 2Y13.8%
EPS Next 3Y12.85%
EPS Next 5Y10.5%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%7.52%
Revenue Next Year22.18%
Revenue Next 2Y13.7%
Revenue Next 3Y11.71%
Revenue Next 5Y8.53%
EBIT growth 1Y10.59%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year43.94%
EBIT Next 3Y18.5%
EBIT Next 5Y14.43%
FCF growth 1Y7.38%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y3.73%
OCF growth 3Y43.4%
OCF growth 5Y57.54%